作者: Thomas R. O'Brien
DOI: 10.1001/JAMA.1992.03480200083029
关键词:
摘要: WITHIN the past year, US Food and Drug Administration (FDA) has licensed two combined human immunodeficiency virus type 1 (HIV-1)/human 2 (HIV-2) enzyme immunoassays (EIAs) for screening donated blood plasma. The FDA also mandated that by June 1, 1992, centers must implement testing antibodies to HIV-2 in addition HIV-1. Implementation of this policy reports HIV-2—infected residents have raised important public health clinical questions about infection United States. This article summarizes current information regarding epidemiology diagnosis discusses considerations arise from presence BACKGROUND: WORLDWIDE DISTRIBUTION, TRANSMISSION, AND NATURAL HISTORY Infection with is endemic many countries West Africa, but generally much rarer elsewhere world. 1,2 highest prevalence